{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:43:11Z","timestamp":1790962991228,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Progetto Dipartimentale"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.pupt.2018.09.003","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:15:15Z","timestamp":1536106515000},"page":"6-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Comorbidities of IPF: How do they impact on prognosis"],"prefix":"10.1016","volume":"53","author":[{"given":"Sebastiano Emanuele","family":"Torrisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Vancheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Pavone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9933-1202","authenticated-orcid":false,"given":"Gianluca","family":"Sambataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7196-2974","authenticated-orcid":false,"given":"Stefano","family":"Palmucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Vancheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2018.09.003_bib1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1164\/rccm.200602-163OC","article-title":"Incidence and prevalence of idiopathic pulmonary fibrosis","volume":"174","author":"Raghu","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"ATS\/ERS\/JRS\/ALAT Committee on Idiopathic Pulmonary Fibrosis, an official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151425","article-title":"Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis","volume":"11","author":"Kreuter","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2018.09.003_bib4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1164\/rccm.200805-725OC","article-title":"The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study","volume":"178","author":"Hubbard","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib5","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1164\/rccm.200912-1951OC","article-title":"Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study","volume":"181","author":"Sode","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1183\/09031936.00041411","article-title":"Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease","volume":"39","author":"Sprunger","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.09.003_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/thoraxjnl-2013-203740","article-title":"Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study","volume":"69","author":"Navaratnam","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2018.09.003_bib8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.rmed.2010.02.008","article-title":"Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis","volume":"104","author":"Nathan","year":"2010","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.rmed.2014.01.008","article-title":"How does comorbidity influence survival in idiopathic pulmonary fibrosis?","volume":"108","author":"Hyldgaard C","year":"2014","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201202-0314OC","article-title":"A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis","volume":"186","author":"Noth","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.pupt.2018.09.003_bib12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3111\/13696998.2012.680553","article-title":"Burden of illness in idiopathic pulmonary fibrosis","volume":"15","author":"Collard","year":"2012","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.pupt.2018.09.003_bib13","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1378\/chest.128.4.2393","article-title":"Pulmonary hypertension in patients with idiopathic pulmonary fibrosis","volume":"128","author":"Nadrous","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.09.003_bib14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1183\/13993003.02316-2014","article-title":"Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review","volume":"46","author":"Raghu","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.09.003_bib15","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.129.3.746","article-title":"Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis","volume":"129","author":"Lettieri","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.09.003_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2014.06.014","article-title":"A consensus document for the selection of lung transplant candidates: 2014\u2014an update from the pulmonary transplantation council of the international society for heart and lung transplantation","volume":"34","author":"Weill","year":"2015","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.pupt.2018.09.003_bib17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1164\/rccm.201011-1874OC","article-title":"BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmo- nary fibrosis","volume":"184","author":"Jr King","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-158-9-201305070-00003","article-title":"ARTEMIS-IPF Investigators, Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial","volume":"158","author":"Raghu","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib19","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1183\/09031936.00104612","article-title":"Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial","volume":"42","author":"Raghu","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.09.003_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.201403-0446OC","article-title":"Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia","volume":"190","author":"Corte","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1002110","article-title":"A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis","volume":"363","author":"Zisman","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib22","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1378\/chest.12-1594","article-title":"IPFnet Investigators, Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction","volume":"143","author":"Han","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.09.003_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1183\/09059180.00003613","article-title":"Common pathways in idiopathic pulmonary fibrosis and cancer","volume":"22","author":"Vancheri","year":"2013","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.pupt.2018.09.003_bib24","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1183\/09031936.00077309","article-title":"Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology","volume":"35","author":"Vancheri","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.09.003_bib25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1440-1843.2009.01547.x","article-title":"Cumulative incidence of and predictive factors for lung cancer in IPF","volume":"14","author":"Ozawa","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.pupt.2018.09.003_bib26","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1440-1843.2010.01907.x","article-title":"The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer","volume":"16","author":"Usui","year":"2011","journal-title":"Respirology"},{"key":"10.1016\/j.pupt.2018.09.003_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161437","article-title":"Lung cancer in combined pulmonary fibrosis and emphysema: a systematic review and meta-analysis","volume":"11","author":"Koo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2018.09.003_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2017.03.016","article-title":"Lung cancer in patients with idiopathic pulmonary fibrosis","volume":"45","author":"Karampitsakos","year":"2017","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.pupt.2018.09.003_bib29","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/his.13269","article-title":"Increased frequency of bronchiolar histotypes in lung carcinomas associated with idiopathic pulmonary fibrosis","volume":"71","author":"Calio","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.pupt.2018.09.003_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1378\/chest.14-0359","article-title":"The impact of lung cancer on survival of idiopathic pulmonary fibrosis","volume":"147","author":"Tomassetti","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.09.003_bib31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1055\/s-2007-965645","article-title":"Operative indications for lung cancer with idiopathic pulmonary fibrosis","volume":"55","author":"Kushibe","year":"2007","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.pupt.2018.09.003_bib32","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.athoracsur.2015.03.094","article-title":"Pulmonary resection for lung cancer in patients with idiopathic interstitial pneumonia","volume":"100","author":"Omori","year":"2015","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.pupt.2018.09.003_bib33","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jtcvs.2008.07.016","article-title":"Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?","volume":"136","author":"Watanabe","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.pupt.2018.09.003_bib34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.05.00021005","article-title":"Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P), Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity","volume":"26","author":"Cottin","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.09.003_bib35","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1073\/pnas.100448997","article-title":"Increased metallo- proteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice","volume":"97","author":"Wert","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pupt.2018.09.003_bib36","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1152\/japplphysiol.00083.2002","article-title":"Pulmonary hypertension in TNF-a-overexpressing mice is associated with decreased VEGF gene expression","volume":"93","author":"Fujita","year":"2002","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.pupt.2018.09.003_bib37","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1164\/rccm.200410-1349OC","article-title":"Tumor necrosis factor-a overexpression in lung disease: a single cause behind a complex phenotype","volume":"171","author":"Lundblad","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1165\/rcmb.2004-0309OC","article-title":"Interleukin-1b causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung","volume":"32","author":"Lappalainen","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.pupt.2018.09.003_bib39","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1440-1843.2010.01778.x","article-title":"The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis","volume":"15","author":"Kurashima","year":"2010","journal-title":"Respirology"},{"key":"10.1016\/j.pupt.2018.09.003_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1378\/chest.08-2306","article-title":"Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension","volume":"136","author":"Mejia","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.09.003_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1378\/chest.12-2403","article-title":"Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis","volume":"144","author":"Ryerson","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.09.003_bib42","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.rmed.2013.11.013","article-title":"Lung cancer risk among patients with combined pulmonary fibrosis and emphysema","volume":"108","author":"Kwak","year":"2014","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib43","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1016\/j.jacc.2013.10.036","article-title":"Pulmonary hypertension in chronic lung diseases","volume":"62","author":"Seeger","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pupt.2018.09.003_bib44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1183\/09059180.00002713","article-title":"Pulmonary hypertension in chronic interstitial lung diseases","volume":"22","author":"Caminati","year":"2013","journal-title":"Eur. Respir. Rev."},{"issue":"suppl 1","key":"10.1016\/j.pupt.2018.09.003_bib45","first-page":"37","article-title":"Gastro-oesophageal reflux and idiopathic pulmonary fibrosis, Sarcoidosis Vasc","volume":"30","author":"Vancheri","year":"2013","journal-title":"Diffuse Lung Dis"},{"key":"10.1016\/j.pupt.2018.09.003_bib46","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1378\/chest.129.3.794","article-title":"Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series","volume":"129","author":"Raghu","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.09.003_bib47","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtcvs.2005.10.014","article-title":"Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation","volume":"131","author":"Linden","year":"2006","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.pupt.2018.09.003_bib48","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1164\/rccm.201101-0138OC","article-title":"Gastroesophageal refl ux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis","volume":"184","author":"Lee","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib49","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S2213-2600(13)70105-X","article-title":"IPFnet Investigators, Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials","volume":"1","author":"Lee","year":"2013","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S2213-2600(16)00067-9","article-title":"Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis","volume":"4","author":"Kreuter","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib51","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s11325-013-0834-3","article-title":"Obstructive sleep apnea is common in patients with interstitial lung disease","volume":"17","author":"Pihtili","year":"2013","journal-title":"Sleep Breath."},{"key":"10.1016\/j.pupt.2018.09.003_bib52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11325-010-0336-5","article-title":"How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis?","volume":"14","author":"Mermigkis","year":"2010","journal-title":"Sleep Breath."},{"key":"10.1016\/j.pupt.2018.09.003_bib53","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1378\/chest.08-2776","article-title":"Obstructive sleep apnea is common in idiopathic pulmonary fibrosis","volume":"136","author":"Lancaster","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.09.003_bib54","doi-asserted-by":"crossref","first-page":"320","DOI":"10.9734\/AIR\/2014\/9740","article-title":"An observational study of anxiety and depression in idiopathic pulmonary fibrosis","volume":"2","author":"Pink","year":"2014","journal-title":"Adv. Res."},{"key":"10.1016\/j.pupt.2018.09.003_bib55","doi-asserted-by":"crossref","first-page":"593","DOI":"10.5664\/jcsm.2758","article-title":"Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis","volume":"9","author":"Kolilekas","year":"2013","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.pupt.2018.09.003_bib56","first-page":"41","article-title":"Elevated nocturnal desaturation index predicts mortality in interstitial lung disease, Sarcoidosis Vasc","volume":"29","author":"Corte","year":"2012","journal-title":"Diffuse Lung Dis"},{"key":"10.1016\/j.pupt.2018.09.003_bib57","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00408-017-0031-4","article-title":"OSA and prolonged oxygen desaturation during sleep are strong predictors of poor outcome in IPF","volume":"195","author":"Bosi","year":"2017","journal-title":"Lung"},{"key":"10.1016\/j.pupt.2018.09.003_bib58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1479972313493098","article-title":"Depression in patients with idiopathic pulmonary fibrosis","volume":"10","author":"Akhtar","year":"2013","journal-title":"Chron. Respir. Dis."},{"key":"10.1016\/j.pupt.2018.09.003_bib59","first-page":"195","article-title":"Depression in patients with idiopathic pulmonary fibrosis","volume":"12","author":"Amin","year":"2014","journal-title":"AAMJ (Alpe Adria Microbiol. J.)"},{"key":"10.1016\/j.pupt.2018.09.003_bib60","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1440-1843.2011.02122.x","article-title":"Depression is a common and chronic comorbidity in patients with interstitial lung disease","volume":"17","author":"Ryerson","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.pupt.2018.09.003_bib61","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/resp.12360","article-title":"Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease","volume":"19","author":"Holland","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.pupt.2018.09.003_bib62","article-title":"Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2018.09.003_bib63","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0053-2017","article-title":"When to start and when to stop antifibrotic therapies","volume":"26","author":"Torrisi","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.pupt.2018.09.003_bib64","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2213-2600(18)30301-1","article-title":"Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 Trial","volume":"6","author":"Raghu","year":"2018","journal-title":"Lancet Respir. Med."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553918301469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553918301469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:27:59Z","timestamp":1761082079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553918301469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":64,"alternative-id":["S1094553918301469"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2018.09.003","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidities of IPF: How do they impact on prognosis","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2018.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}